Morphine-6-glucuronide, an active morphine metabolite for the potential treatment of post-operative pain

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Morphine-6-glucuronide (M6G) is an active metabolite of morphine that is being developed by CeNeS Pharmaceuticals as an alternative to morphine (the most commonly used opioid) for the management of postoperative pain. M6G is currently undergoing phase III clinical trials in patients with postoperative pain.

Original languageEnglish (US)
Pages (from-to)786-799
Number of pages14
JournalCurrent Opinion in Investigational Drugs
Volume9
Issue number7
StatePublished - Jul 2008

Fingerprint

Postoperative Pain
Morphine
Pain
Phase III Clinical Trials
Opioid Analgesics
Therapeutics
Pharmaceutical Preparations
morphine-6-glucuronide

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{ad49d3b53e2a4fa9b280237a93f140e8,
title = "Morphine-6-glucuronide, an active morphine metabolite for the potential treatment of post-operative pain",
abstract = "Morphine-6-glucuronide (M6G) is an active metabolite of morphine that is being developed by CeNeS Pharmaceuticals as an alternative to morphine (the most commonly used opioid) for the management of postoperative pain. M6G is currently undergoing phase III clinical trials in patients with postoperative pain.",
author = "Joshi, {G. P.}",
year = "2008",
month = "7",
language = "English (US)",
volume = "9",
pages = "786--799",
journal = "Current Opinion in Investigational Drugs",
issn = "1354-3784",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Morphine-6-glucuronide, an active morphine metabolite for the potential treatment of post-operative pain

AU - Joshi, G. P.

PY - 2008/7

Y1 - 2008/7

N2 - Morphine-6-glucuronide (M6G) is an active metabolite of morphine that is being developed by CeNeS Pharmaceuticals as an alternative to morphine (the most commonly used opioid) for the management of postoperative pain. M6G is currently undergoing phase III clinical trials in patients with postoperative pain.

AB - Morphine-6-glucuronide (M6G) is an active metabolite of morphine that is being developed by CeNeS Pharmaceuticals as an alternative to morphine (the most commonly used opioid) for the management of postoperative pain. M6G is currently undergoing phase III clinical trials in patients with postoperative pain.

UR - http://www.scopus.com/inward/record.url?scp=46749096466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46749096466&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 786

EP - 799

JO - Current Opinion in Investigational Drugs

JF - Current Opinion in Investigational Drugs

SN - 1354-3784

IS - 7

ER -